| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871763 | The Annals of Thoracic Surgery | 2015 | 7 Pages |
Abstract
In stage IIIA NSCLC, the selective addition of surgical resection to CR is cost-effective compared with definitive chemoradiation therapy at nonacademic and academic centers. These conclusions are valid over a range of clinically meaningful variations in cost and treatment outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pamela MD, Aalok BS, Cliff G. MD, Daniel MD, Su-Hsin PhD, Graham A. MD, Saiama MD, Traves D. MD, A. Sasha MD, Daniel MD, G. Alexander MD, Bryan F. MD, MPH, Varun MD, MSCI,